![](https://d197nivf0nbma8.cloudfront.net/uploads/2024/07/Penn-LDI-LinkedIn_Policy-RachelNorma2-520x438.jpg)
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
Opioid Epidemic
News
As the U.S. Senate Committee on Health, Education, Labor, and Pensions began considering legislation to recharge the national effort to address the opioid epidemic and overdose death rate, a contingent of academic researchers from the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI) and the University of Pittsburgh Medical Center (UPMC) conducted a virtual briefing for a bipartisan group of committee staffers regarding the evidence.
The committee’s work is focused on a proposal for the refunding of the soon-to-expire programs of the 2018 Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). The act was a landmark piece of legislation and the largest congressional investment in overdose prevention at that time, supporting a broad range of programs aimed at expanding services and their reach across all aspects of substance use disorder treatment.
The new Senate effort is backgrounded by that fact that 80,000 people (222 per day) continue to die annually of opioid overdoses.
While the committee’s new version of the SUPPORT Act continues and augments many of those previously established programs, it is also considering proposals to include several other pieces of new addiction-related legislation. One of these is the Modernizing Opioid Treatment Access Act (MOTAA) that would alter how methadone is regulated and expand how it is distributed for opioid use disorder (OUD).
Methadone, a synthetic opioid designed not to produce a high while it prevents addiction withdrawal symptoms and cravings, is strictly regulated by current Food and Drug Administration (FDA) regulations. A drug taken once a day, it can only be dispensed by opioid treatment program (OTP) locations certified by the Substance Abuse and Mental Health Services Administration (SAMHSA). SAMSHA’s highly restrictive guidelines significantly limit the number of OUD patients who have access to the drug, which is considered the gold standard for OUD treatments because of the overwhelming evidence of its effectiveness.
In their December 4 virtual meeting with a bipartisan group of Senate committee staffers, the six-member Penn LDI/UPC team of addiction and recovery specialists reviewed the evidence that suggests that making methadone more accessible through pharmacy prescriptions could reduce overdose deaths.
The team members were Ashish Thakrar, MD, MS, LDI Associate Fellow from the Perelman School of Medicine; David Mandell, ScD, LDI Senior Fellow and Director of the Penn Center for Mental Health; Jeffrey Jaeger, MD, FASAM LDI Senior Fellow from Perelman; Julia Hinckley, JD, Director of Policy Strategy at LDI; Paul Joudrey, MD, MPH, of UPMC; and Cambria King of UPMC.
Among the evidence addressed by the team of researchers:
Presented to U.S. Senator Elizabeth Warren
Policymakers Should Consider Reporting and Planning Procedures That Do Not Involve Child Protective Services
The Braidwood Case Opens the Door For Others To Block PrEP and other Preventive Services
It’s the First National Database to Measure the Impact of Environmental Factors on Health
Changing the Health Care Reimbursement Model Could Improve Quality and Lower Costs
Home-Based Programs Hold Promise to Improve Their Health